Supply of Antibody Detection and Identification Panels

The contract involves the supply of antibody screening cells and identification panels designed to detect non-ABO antibodies, with a requirement for at least 30 unique donor cells to ensure comprehensive coverage of clinically significant antigen systems including Kell, Duffy, and Kidd. These panels are essential for accurate blood compatibility testing and must meet stringent quality and specificity standards to support safe transfusion practices. The work is being procured as a subcontract under the Department of Veterans Affairs, specifically through the 262-NETWORK Contract Office 22, and is classified under NAICS code 325413, which pertains to the manufacturing of in vitro diagnostic substances. Performance of the contract is not tied to a specific location, indicating flexibility in where the panels will be produced or delivered, but all materials must comply with the specified technical requirements for sensitivity and reliability. The solicitation was posted on July 1, 2026, with a firm deadline for responses on July 22, 2026, at 2:00 PM. There is no set-aside classification indicated, meaning the opportunity is open to all eligible vendors regardless of business size or ownership characteristics. The contract is intended to support the Veterans Health Administration's laboratory services and blood bank operations by ensuring a consistent, high-quality supply of antibody detection tools. Successful bidders must demonstrate the ability to reliably provide panels with verified donor cell pedigrees, validated reactivity profiles, and traceable sourcing to maintain compliance with transfusion medicine standards. While no point of contact is listed, interested parties can access further details through the provided SAM.gov link.